Is a complete SHA/688513 research report available?

Question

Accepted Answer

No complete published report is available for sha/688513 (SHA/688513) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Volume
Market cap	8.2B
Revenue (ttm)	1.4B
Net income (ttm)	274.3M
EPS (ttm)	CN¥1.58
Shares out	174.4M
P/E (trailing)	29.9x
P/E (forward)	27.8x
Dividend	CN¥0.49 (1.00%)

Metric	Value
Country	China
Country code	CN
Employees	1,480
Employees Change	-42%
Employees Change Percent	-2.76
Enterprise value	CNY 6.8B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	34.03
Isin	CNE100004397
Last refreshed	2026-07-29
Market cap	CNY 8.2B
Price	CNY 46.8
Price currency	CNY
Rev Per Employee	913,522.16x
Sector	Healthcare
Sector PE	39.51
Sector PE Fwd	22.32
Sic	2834
Symbol	sha/688513
Website	https://www.eastonpharma.cn

Metric	Value
Earnings Yield	3.33%
EV Earnings	24.75x
EV/EBIT	37.18x
EV/EBITDA	24.63x
EV/FCF	30.79x
EV/Sales	5.02x
FCF yield	2.68%
Forward P/E	27.76x
P/B ratio	2.67x
P/E ratio	29.86x
P/S ratio	6.09x
PE Ratio3 Y	30.54x
PE Ratio5 Y	28.46x

Metric	Value
EBIT Margin	13.5%
EBITDA Margin	20.38%
FCF margin	16.31%
Gross margin	74.4%
Gross Profit	CNY 1B
Gross Profit Growth	1.09%
Gross Profit Growth Q	4.43%
Gross Profit Growth3 Y	1.02%
Gross Profit Growth5 Y	3.3%
Net Income	CNY 274.3M
Net Income Growth	22.56%
Net Income Growth Q	-16.11%
Net Income Growth Years	2%
Net Income Growth3 Y	2.64%
Net Income Growth5 Y	7.53%
Pretax Margin	21.05%
Profit Margin	20.29%
Profit Per Employee	CNY 185,338
Profitable Quarters	CNY 34
Profitable Years	13
ROA	3.15
Roa5y	3.23
ROCE	5.66
ROE	8.76
Roe5y	9.7
ROIC	10.54
Roic5y	13.91

Metric	Value
Cagr1y	-14.27%
Cagr3y	13.02%
Cagr5y	9.76%
Div CAGR3	8.75%
EPS Growth	24.38
EPS Growth Q	-14.71
EPS Growth Years	2
EPS Growth3 Y	3.27
EPS Growth5 Y	5.56
FCF Growth	45.1%
FCF Growth Q	113.92%
OCF Growth	29.64%
OCF Growth Q	95.18%
OCF Growth3 Y	28.26%
OCF Growth5 Y	13.59%
Revenue Growth	0.87x
Revenue Growth Q	6.75x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	4.66x
Revenue Growth5 Y	6.94x

SHA/688513 (SHA/688513)

Coverage state: Market snapshot only — no published research

Generate the first SHA/688513 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/688513

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/688513 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SHA/688513

Frequently asked questions

Metric	Value
Asset Turnover	CNY 0.37
Assets	CNY 3.8B
Cash	CNY 1.6B
Current Assets	CNY 2.1B
Current Liabilities	CNY 553.6M
Debt	CNY 81.3M
Debt EBITDA	CNY 0.3
Debt Equity	CNY 0.03
Debt FCF	CNY 0.37
Equity	CNY 3.1B
Interest Coverage	77.08
Liabilities	CNY 691.5M
Long Term Assets	CNY 1.7B
Long Term Liabilities	CNY 137.8M
Net Cash	CNY 1.5B
Net Cash By Market Cap	CNY 18.72
Net Cash Growth	14.09%
Net Debt EBITDA	CNY -5.59
Net Debt Equity	CNY -0.5
Net Debt FCF	CNY -6.99
Tangible Book Value	CNY 2.8B
Tangible Book Value Per Share	CNY 15.84
WACC	4.33

Metric	Value
Current ratio	3.82
Inventory Turnover	1.5
Net Working Capital	CNY -8M
Quick ratio	3.32
Working Capital	CNY 1.6B
Working Capital Turnover	CNY 0.91

Metric	Value
Buyback Yield	1.46%
Dividend Growth	13.95%
Dividend Growth Years	0%
Dividend per share	CNY 0.49
Dividend Years	6
Dividend Yield	1%
Ex Div Date	2026-06-02
Last Dividend	CNY 0.49
Payout Frequency	Annual
Payout Ratio	27.9%

Metric	Value
1Y total return	-14.26%
200-day SMA	57.4
3Y total return	44.39%
50-day SMA	50.2
50-day SMA vs 200-day SMA	50under200
5Y total return	59.29%
All Time High	80.48
All Time High Change	-41.35%
All Time High Date	2026-04-02
All Time Low	28.11
All Time Low Change	67.91%
All Time Low Date	2024-07-30
ATR	4.25
Beta	0.02
Beta1y	-0.09
Beta2y	0.16
Ch YTD	-23.31
High	48.8
High52	80.48
High52 Date	2026-04-02
High52ch	-41.85%
Low	46.5
Low52	40.25
Low52 Date	2026-06-29
Low52ch	16.27%
Ma50ch	-5.97%
Price vs 200-day SMA	-17.77%
RSI	41
RSI Monthly	48.64
RSI Weekly	42.23
Sharpe ratio	0.47x
Sortino ratio	0.87
Total Return	2.46%
Tr YTD	-22.54
Tr1m	13.65%
Tr1w	-13.16%
Tr3m	-27.71%

Metric	Value
Operating Income	CNY 182.6M
Operating Income Growth	19.93
Operating Income Growth Q	-28.72
Operating Income Growth3 Y	2.84
Operating Income Growth5 Y	7.3
Operating margin	13.5

Metric	Value
Float	80,466,173%
Net Borrowing	-38,666,666
Shares Insiders	48.82%
Shares Institutions	19.28%
Shares Out	174,352,910
Shares Qo Q	3.91%
Shares Yo Y	-1.46%

Metric	Value
Average Volume	4,579,424x
Bv Per Share	17.13
CAPEX	CNY -91.1M
Ch1m	13.65
Ch1w	-13.16
Ch1y	-15.12
Ch3m	-28.43
Ch3y	39.94
Ch5y	50.21
Ch6m	-16.24
Change	-0.85%
Change From Open	0.65
Close	47.2
Days Gap	-1.48
Depreciation Amortization	93,023,036
Dollar Volume	20,735,301.6
Earnings Date	2026-08-21
EBIT	CNY 182.6M
EBITDA	CNY 275.6M
EPS	CNY 1.58
F Score	7
FCF	CNY 220.5M
FCF EV Yield	3.25x
FCF Per Share	CNY 1.26
Financing CF	-120,738,102
Fiscal Year End	December
Founded	2,009
Goodwill	23,099,384
Graham Number	24.68522
Graham Upside	-47.7
Income Tax	CNY 28.4M
Investing CF	-368,762,291
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2024-07-01
Last Split Type	Forward
Lynch Fair Value	CNY 11.91
Lynch Upside	-74.77
Ma150	58.34
Ma150ch	-19.09%
Ma20	54.1
Ma20ch	-12.75%
Net CF	-178,874,249
Next Earnings Date	2026-08-21
Open	46.5
P FCF Ratio	37.33
P OCF Ratio	26.42
Payment Date	2026-06-02
Position In Range	13.04
Ppne	1,212,575,138
Price Date	2026-07-29
Price EBITDA	CNY 29.86
Ptbv Ratio	2.98
Relative Volume	0.1x
Revenue	1,352,012,801x
Tax By Revenue	2.1x
Tax Rate	9.97%
Tr6m	-15.39%
Volume	443,062
Z Score	9.48